DrugDashboards

Tranexamic Acid

Tranexamic Acid · TRANEXAMIC ACID 100 mg/mL · Injection, Solution · Intravenous · Eugia US LLC

NDC 55150-0188-10 · 10 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

21 companies supply this market — deep enough that no single failure threatens the supply. The price is up 11% over the past year, to $0.3868 per mL. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.6% of the time — roughly 4× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.3868per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$1.68per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4Jun 2024Sep 2026$0.3868
19 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$60.00
Reported to Texas DSHS · 2026 annual filing · Eugia Us Llc

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$43,572
1,553 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

10Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.6%chance of a new FDA shortage posting for tranexamic acid (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $48.39 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA205035
TE code
AP
Approval date
Jan 14, 2016
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · OngoingSep 26, 2022
    AuroMedics Pharma LLCPresence of Particulate Matter: Piece of metal found in a vial

Manufacturers of Tranexamic Acid (Injection, Solution)

LabelerStrengthFirst seenLast seen
Amneal Pharmaceuticals Private LimitedTRANEXAMIC ACID 10 mg/mLJul 15, 2026Sep 3, 2026
Heritage Pharmaceuticals Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.TRANEXAMIC ACID 1 g/10mLJul 15, 2026Sep 3, 2026
Milla Pharmaceuticals Inc.TRANEXAMIC ACID 100 mg/mLSep 3, 2026Sep 3, 2026
Amneal Pharmaceuticals LLCTRANEXAMIC ACID 100 mg/mLJul 15, 2026Sep 2, 2026
Apotex Corp.TRANEXAMIC ACID 100 mg/mLJul 15, 2026Sep 2, 2026
Avenacy Inc.TRANEXAMIC ACID 10 mg/mLJul 15, 2026Sep 2, 2026
Avenacy, Inc.TRANEXAMIC ACID 100 mg/mLJul 15, 2026Sep 2, 2026
Emcure Pharmaceuticals LimitedTRANEXAMIC ACID 1 g/10mLJul 15, 2026Sep 2, 2026
Eugia US LLCTRANEXAMIC ACID 100 mg/mLJul 15, 2026Sep 2, 2026
Exela Pharma Sciences, LLCTRANEXAMIC ACID 10 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCTRANEXAMIC ACID 10 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedTRANEXAMIC ACID 10 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedTRANEXAMIC ACID 100 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstTRANEXAMIC ACID 100 mg/mLJul 15, 2026Sep 2, 2026
HP Halden Pharma ASTRANEXAMIC ACID 10 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCTRANEXAMIC ACID 100 mg/mLJul 15, 2026Sep 2, 2026
Nexus Pharmaceuticals LLCTRANEXAMIC ACID 10 mg/mLJul 15, 2026Sep 2, 2026
Pfizer Laboratories Div Pfizer IncTRANEXAMIC ACID 100 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsTRANEXAMIC ACID 100 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsTRANEXAMIC ACID 10 mg/mLJul 15, 2026Sep 2, 2026
XGen Pharmaceuticals DJB, Inc.TRANEXAMIC ACID 100 mg/mLJul 15, 2026Sep 2, 2026
Provepharm Inc.TRANEXAMIC ACID 100 mg/mLJul 15, 2026Aug 28, 2026
American Regent, Inc.TRANEXAMIC ACID 100 mg/mLJul 15, 2026Aug 12, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Tranexamic Acid — NDC 55150-0188-10," retrieved September 3, 2026, https://drugdashboards.com/drug/55150018810.

Free to cite with attribution — see how the data is put together.